HuGE Literature Finder
Records 1-11
|
The Association of Single-Nucleotide Polymorphism rs13181 in ERCC2 with Risk and Prognosis of Nasopharyngeal Carcinoma in an Endemic Chinese Population.
Pharmacogenomics and personalized medicine 2021 14 359-367. Wei Zhengbo, Yao Mengwei, Ning Sisi, Wu Yuan, Zhou Xunzhao, Zhong Changtao, Yan Kui, Xie Yi |
|
Targeted deep sequencing of urothelial bladder cancers and associated urinary DNA: a 23-gene panel with utility for non-invasive diagnosis and risk stratification.
BJU international 2019 May . Ward D G, Gordon N S, Boucher R H, Pirrie S J, Baxter L, Ott S, Silcock L, Whalley C M, Stockton J D, Beggs A D, Griffiths M, Abbotts B, Ijakipour H, Latheef F N, Robinson R, White A J, James N D, Zeegers M P, Cheng K K, Bryan R |
|
Impact of DNA repair gene polymorphisms on the risk of biochemical recurrence after radiotherapy and overall survival in prostate cancer.
Oncotarget 2017 Feb . Zanusso Chiara, Bortolus Roberto, Dreussi Eva, Polesel Jerry, Montico Marcella, Cecchin Erika, Gagno Sara, Rizzolio Flavio, Arcicasa Mauro, Novara Giacomo, Toffoli Giusep |
|
Genomic characterization of response to chemoradiation in urothelial bladder cancer.
Cancer 2016 Aug . Desai Neil B, Scott Sasinya N, Zabor Emily C, Cha Eugene K, Hreiki Joseph, Sfakianos John P, Ramirez Ricardo, Bagrodia Aditya, Rosenberg Jonathan E, Bajorin Dean F, Berger Michael F, Bochner Bernard H, Zelefsky Michael J, Kollmeier Marisa A, Ostrovnaya Irina, Al-Ahmadie Hikmat A, Solit David B, Iyer Go |
|
A systematic review and meta-analysis of somatic and germline DNA sequence biomarkers of esophageal cancer survival, therapy response and stage.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2015 Apr 26 (4): 624-44. Findlay J M, Middleton M R, Tomlinson |
|
Whole-exome sequencing of muscle-invasive bladder cancer identifies recurrent mutations of UNC5C and prognostic importance of DNA repair gene mutations on survival.
Clinical cancer research : an official journal of the American Association for Cancer Research 2014 Dec 20 (24): 6605-17. Yap Kai Lee, Kiyotani Kazuma, Tamura Kenji, Antic Tatjana, Jang Miran, Montoya Magdeline, Campanile Alexa, Yew Poh Yin, Ganshert Cory, Fujioka Tomoaki, Steinberg Gary D, O'Donnell Peter H, Nakamura Yusu |
|
Analysis of over 10,000 Cases finds no association between previously reported candidate polymorphisms and ovarian cancer outcome.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2013 May 22 (5): 987-92. White Kristin L, Vierkant Robert A, Fogarty Zachary C, Charbonneau Bridget, Block Matthew S, Pharoah Paul D P, Chenevix-Trench Georgia, , Rossing Mary Anne, Cramer Daniel W, Pearce Celeste Leigh, Schildkraut Joellen M, Menon Usha, Kjaer Susanne Kruger, Levine Douglas A, Gronwald Jacek, Culver Hoda Anton, Whittemore Alice S, Karlan Beth Y, Lambrechts Diether, Wentzensen Nicolas, Kupryjanczyk Jolanta, Chang-Claude Jenny, Bandera Elisa V, Hogdall Estrid, Heitz Florian, Kaye Stanley B, Fasching Peter A, Campbell Ian, Goodman Marc T, Pejovic Tanja, Bean Yukie, Lurie Galina, Eccles Diana, Hein Alexander, Beckmann Matthias W, Ekici Arif B, Paul James, Brown Robert, Flanagan James M, Harter Philipp, du Bois Andreas, Schwaab Ira, Hogdall Claus K, Lundvall Lene, Olson Sara H, Orlow Irene, Paddock Lisa E, Rudolph Anja, Eilber Ursula, Dansonka-Mieszkowska Agnieszka, Rzepecka Iwona K, Ziolkowska-Seta Izabela, Brinton Louise, Yang Hannah, Garcia-Closas Montserrat, Despierre Evelyn, Lambrechts Sandrina, Vergote Ignace, Walsh Christine, Lester Jenny, Sieh Weiva, McGuire Valerie, Rothstein Joseph H, Ziogas Argyrios, Lubinski Jan, Cybulski Cezary, Menkiszak Janusz, Jensen Allan, Gayther Simon A, Ramus Susan J, Gentry-Maharaj Aleksandra, Berchuck Andrew, Wu Anna H, Pike Malcolm C, Van Denberg David, Terry Kathryn L, Vitonis Allison F, Doherty Jennifer A, Johnatty Sharon E, Defazio Anna, Song Honglin, Tyrer Jonathan, Sellers Thomas A, Phelan Catherine M, Kalli Kimberly R, Cunningham Julie M, Fridley Brooke L, Goode Ellen |
|
Effects of ERCC2 Lys751Gln (A35931C) and CCND1 (G870A) polymorphism on outcome of advanced-stage squamous cell carcinoma of the head and neck are treatment dependent.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2011 Nov 20 (11): 2429-37. Zhong Shilong, Nukui Tomoko, Buch Shama, Diergaarde Brenda, Weissfeld Lisa A, Grandis Jennifer, Romkes Marjorie, Weissfeld Joel |
|
Polymorphisms in ABCB1 and ERCC2 associated with ovarian cancer outcome.
International journal of molecular epidemiology and genetics 2011 2 (2): 185-95. Peethambaram Prema, Fridley Brooke L, Vierkant Robert A, Larson Melissa C, Kalli Kimberly R, Elliott Elaine A, Oberg Ann L, White Kristin L, Rider David N, Keeney Gary L, Cunningham Julie M, Hartmann Lynn C, Goode Ellen |
|
Impact of nucleotide excision repair ERCC2 and base excision repair APEX1 genes polymorphism and its association with recurrence after adjuvant BCG immunotherapy in bladder cancer patients of North India.
Medical oncology (Northwood, London, England) 2010 Jun 27 (2): 159-66. Gangawar Ruchika, Ahirwar Dinesh, Mandhani Anil, Mittal Rama De |
|
Independent Replication of Published Germline Polymorphisms Associated with Urinary Bladder Cancer Prognosis and Treatment Response.
Bladder cancer 0 2 (1): 77-89. Grotenhuis Anne J, Dudek Aleksandra M, Verhaegh Gerald W, Aben Katja K, Witjes J Alfred, Kiemeney Lambertus A, Vermeulen Sita |
- Page last reviewed:Oct 1, 2020
- Page last updated:May 12, 2021
- Content source: